Before a Request is Made

Before deciding whether this drug might be appropriate for your patient, please read our Investigator’s Brochure and Scientific Overview which detail RLF-100’s mechanism of action, indications, dosing and administration, and known adverse events.

Request Expanded Access for your Patients

When you have finished reading the Investigator Brochure, if you would like to proceed with being registered and approved for the RLF100 Expanded Access Program, under which aviptadil may be made available for your patients, please begin by filling out the form below.

Please note that we are receiving a very high volume of requests
and we are working expeditiously to address these.

(Respiratory Failure is defined by the FDA as the requirement for mechanical ventilation, non-invasive ventilation, or high-flow nasal oxygen in excess of 20L/hr in order to maintain blood oxygen saturation.)
At this time, we are focused on institutions that expect to treat numerous patients under an Expanded Access Program.

Get information about the COVID-19 Expanded Access program